Welcome to lbbc.org's website community for women living with metastatic breast cancer. We are dedicated to assisting you, and these pages offer easy access to a wealth of cutting-edge information specific to your needs.
In this community, you can read about the latest news on advanced disease, treatments and updates on clinical trials. Use the navigation bar on the left to quickly and easily access the topics of interest to you.
We hope the information and support offered in this section brings you comfort and enables you to make informed decisions regarding your physical and emotional health.
Every dollar you give helps LBBC continue to provide information and support at little to no cost.
- Phase II Study Shows New Medicine May Slow Metastatic Breast Cancer
- Study Finds Higher Dose of Fulvestrant Reduces Risk of Death
- Physical Activity After Breast Cancer May Improve Quality of Life
- Perjeta Safe and Effective for Older Women With HER2-positive Metastatic Breast Cancer
- News From 2013 SABCS
Baltimore-based researchers seek participants with metastatic breast cancer for a phase II trial comparing a combination of chemotherapy plus a cancer vaccine with or without trastuzumab.
Postmenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer that continued to grow during or after treatment with an aromatase inhibitor (anastrozole, letrozole, and exemestane) are needed for a clinical trial. Researchers conducting the trial are examining the safety and effectiveness of combining the PI3K inhibitor BMK120 with fulvestrant (Faslodex).
Living Beyond Breast Cancer expert Neal Niznan, LCSW, answered your questions about how a metastatic breast cancer diagnosis may affect your mood, how to cope with difficult emotions, ways to manage your emotional concerns along with those of your family and friends, and where to find resources for peer or professional support.